Human Longevity, Inc. (HLI), a global leader in precision health and longevity medicine, today announced that artificial ...

SOUTH SAN FRANCISCO, Calif., Feb. 9, 2026 /PRNewswire/ -- Human Longevity, Inc. (HLI), the global leader in precision health and longevity medicine, today announced that renowned computational ...

Partnership will leverage precision longevity technologies to study centenarians and supercentenarians, unlocking insights into healthy aging SOUTH SAN FRANCISCO, Calif., March 25, 2026 /PRNewswire/ - ...

SOUTH SAN FRANCISCO, Calif., May 6, 2025 /PRNewswire/ -- Human Longevity, Inc. (HLI), the global leader in precision health and longevity medicine, today announced the expansion of its cancer ...

Working with J. Craig Venter's Human Longevity Inc, the Wellcome Trust Sanger Institute and Finland's Institute for Molecular Medicine, AstraZeneca — and its biologics R&D arm MedImmune — plans to ...

Through its Executive Health Program and 100+ Longevity Programs, Human Longevity has delivered care to over 10,000 members using a comprehensive platform that integrates whole genome sequencing, ...

Empowering the future of aging research: Human Longevity to sponsor ARDD 2025, the world's largest conference on aging research in the biopharmaceutical industry The University of Copenhagen is ...

SAN DIEGO--(BUSINESS WIRE)--Human Longevity, Inc. (HLI), an innovator in providing data-driven health intelligence and precision health to physicians and patients, announced today the publication of a ...

The MarketWatch News Department was not involved in the creation of this content. Partnership will leverage precision longevity technologies to study centenarians and supercentenarians, unlocking ...